TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/3614PMID 20036814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors

  2009cited by this paper
• New insights of epithelial-mesenchymal transition in cancer metastasis.

  2008cited by this paper
• Transforming growth factor-β signaling and ubiquitinators in cancer

  2008cited by this paper
• Inhibitory B7-family molecules in the tumour microenvironment

  2008cited by this paper
• A very private TGF-beta receptor embrace.

  2008influential reference
• The characterization and role of regulatory T cells in immune reactions.

  2008cited by this paper
• LY2109761, a novel transforming growth factor β receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis

  2008cited by this paper
• TGFβ is responsible for skin tumour infiltration by macrophages enabling the tumours to escape immune destruction

  2008cited by this paper
• Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis.

  2008cited by this paper
• Antitransforming growth factor-β therapy in fibrosis: recent progress and implications for systemic sclerosis

  2008cited by this paper
• Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms.

  2008cited by this paper
• TGF-β Signaling in Neuronal Stem Cells

  2008influential reference
• Pro- and anti-fibrotic effects of TGF-beta in scleroderma.

  2008cited by this paper
• Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.

  2008cited by this paper
• Metastatic cancer cell.

  2008cited by this paper
• Treatment of transforming growth factor-beta-insensitive mouse Renca tumor by transforming growth factor-beta elimination.

  2008cited by this paper
• TGF-beta-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis.

  2008cited by this paper
• TGFβ‐mediated BIM expression and apoptosis are regulated through SMAD3‐dependent expression of the MAPK phosphatase MKP2

  2008influential reference
• Anti-infective and anti-tumor agents based on the depletion of immune suppressive effects.

  2008cited by this paper
• Inflammation: gearing the journey to cancer.

  2008cited by this paper
• TGF-beta suppresses EGF-induced MAPK signaling and proliferation in asthmatic epithelial cells.

  2008cited by this paper
• Transforming growth factor-beta (TGF-beta) and brain tumours.

  2008cited by this paper
• Oncogenic Ras and Transforming Growth Factor-β Synergistically Regulate AU-Rich Element–Containing mRNAs during Epithelial to Mesenchymal Transition

  2008cited by this paper
• A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.

  2008cited by this paper
• PGE2 induces angiogenesis via MT1-MMP-mediated activation of the TGFbeta/Alk5 signaling pathway.

  2008cited by this paper
• The role of platelet activation in tumor metastasis

  2008cited by this paper
• TGF-beta antisense oligonucleotides modulate expression of matrix metalloproteinases in isolated fibroblasts from radiated skin.

  2008cited by this paper
• Doxorubicin inhibits TGF-beta signaling in human lung carcinoma A549 cells.

  2008cited by this paper
• TGF-beta1 induced MMP-9 expression in HNSCC cell lines via Smad/MLCK pathway.

  2008cited by this paper
• Structure–function relationship of inhibitory Smads: Structural flexibility contributes to functional divergence

  2008cited by this paper
• Targeting TGF-beta and the extracellular matrix in Marfan's syndrome.

  2008cited by this paper
• The tumor microenvironment and its contribution to tumor evolution toward metastasis

  2008influential reference
• Regulation of human cripto‐1 gene expression by TGF‐β1 and BMP‐4 in embryonal and colon cancer cells

  2008cited by this paper
• Abrogation of TGF-beta by antisense oligonucleotides modulates expression of VEGF and increases angiogenic potential in isolated fibroblasts from radiated skin.

  2008cited by this paper
• Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.

  2008cited by this paper
• A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk

  2007cited by this paper
• Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling.

  2007cited by this paper
• Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway.

  2007cited by this paper
• Tumor Evasion of the Immune System by Converting CD4+CD25− T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-β

  2007cited by this paper
• TGF-beta and BMP7 interactions in tumour progression and bone metastasis.

  2007cited by this paper
• Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy

  2007cited by this paper
• A delicate balance: TGF‐β and the tumor microenvironment

  2007cited by this paper
• Differentiation plasticity regulated by TGF-|[beta]| family proteins in development and disease

  2007cited by this paper
• Differentiation plasticity regulated by TGF-β family proteins in development and disease

  2007cited by this paper
• Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+ regulatory T cells

  2007cited by this paper
• Transforming Growth Factor-β and the Immune Response to Malignant Disease

  2007influential reference
• Transforming growth factor-beta signaling in normal and malignant hematopoiesis.

  2007cited by this paper
• REVIEW ARTICLE: Harnessing the Immune System for Ovarian Cancer Therapy

  2007cited by this paper
• Mechanisms underlying TGF‐β1‐induced expression of VEGF and Flk‐1 in mouse macrophages and their implications for angiogenesis

  2007influential reference
• Epithelial-mesenchymal transition and tumour invasion.

  2007influential reference
• Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer.

  2007influential reference
• The evolving concept of tumor microenvironments

  2007cited by this paper
• Smad4-independent TGF-beta signaling in tumor cell migration.

  2007cited by this paper
• TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen.

  2007cited by this paper
• Inhibition of the TGF-beta signaling pathway in tumor cells.

  2007influential reference
• TGFbeta signalling in control of T-cell-mediated self-reactivity.

  2007cited by this paper
• TGF-β insensitive dendritic cells: an efficient vaccine for murine prostate cancer

  2007cited by this paper
• Basics of TGF-beta and pancreatic cancer.

  2007cited by this paper
• TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease.

  2007cited by this paper
• CD4+CD25+ T regulatory cells and TGF-beta in mucosal immune system: the good and the bad.

  2007cited by this paper
• EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells.

  2007cited by this paper
• Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

  2007cited by this paper
• Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

  2007cited by this paper
• Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

  2006cited by this paper
• Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo

  2006cited by this paper
• Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells.

  2006cited by this paper
• Regulation of Smad activities.

  2006influential reference
• Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer

  2006cited by this paper
• The multifaceted roles of chemokines in malignancy

  2006cited by this paper
• Tumor suppressor menin: the essential role of nuclear localization signal domains in coordinating gene expression

  2006cited by this paper
• Transforming growth factor-beta: An important role in CD4+CD25+ regulatory T cells and immune tolerance

  2006cited by this paper
• Transforming growth factor-beta in cancer and metastasis.

  2006cited by this paper
• Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action.

  2006cited by this paper
• Inflammatory chemokines in cancer growth and progression.

  2006cited by this paper
• The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

  2006cited by this paper
• ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells.

  2006cited by this paper
• Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism

  2006cited by this paper
• TGF-beta and cancer.

  2006cited by this paper
• CD25[+]CD4[+] regulatory T cells in patients with Kawasaki disease

  2006cited by this paper
• Regulation of the Polarity Protein Par6 by TGFß Receptors Controls Epithelial Cell Plasticity

  2005cited by this paper
• The role of cetuximab in the treatment of squamous cell cancer of the head and neck

  2005cited by this paper
• The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β

  2005cited by this paper
• Cellular and molecular facets of keratinocyte reepithelization during wound healing.

  2005cited by this paper
• Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis

  2005cited by this paper
• Repression of Bone Morphogenetic Protein and Activin-inducible Transcription by Evi-1*

  2005cited by this paper
• Tumor cell invasiveness correlates with changes in integrin expression and localization

  2005cited by this paper
• Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.

  2005cited by this paper
• Non-Smad TGF-beta signals.

  2005cited by this paper
• Tumor cells convert immature myeloid dendritic cells into TGF-β–secreting cells inducing CD4+CD25+ regulatory T cell proliferation

  2005cited by this paper
• Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A

  2005cited by this paper
• High-Throughput Mapping of a Dynamic Signaling Network in Mammalian Cells

  2005cited by this paper
• Cutting Edge: Direct Suppression of B Cells by CD4+CD25+ Regulatory T Cells1

  2005cited by this paper
• Molecular characterization of the tumor microenvironment in breast cancer.

  2004cited by this paper
• GADD34–PP1c recruited by Smad7 dephosphorylates TGFβ type I receptor

  2004cited by this paper
• SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells In vitro and In vivo

  2004cited by this paper
• Effects of ectopic decorin in modulating intracranial glioma progression in vivo, in a rat syngeneic model

  2004cited by this paper
• Malignant Cells, Directors of the Malignant Process: Role of Transforming Growth Factor-beta

  2004cited by this paper
• Amelioration of Radiation-induced Fibrosis

  2004cited by this paper
• Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition.

  2004cited by this paper
• Role of Rho/ROCK and p38 MAP Kinase Pathways in Transforming Growth Factor-β-mediated Smad-dependent Growth Inhibition of Human Breast Carcinoma Cells in Vivo*

  2004cited by this paper

• Lemon gum (Citrus x latifolia) enhances IL-1Β expression and suppresses colon tumor growth in vivo with a favorable safety profile.

  2026cites this paper
• Targeting BMP-1 enhances anti-tumoral effects of doxorubicin in metastatic mammary cancer: common and distinct features of TGF-β inhibition

  2025cites this paper
• Recent Advancements in Breast Cancer Therapies and Biomarkers: Mechanisms and Clinical Significance.

  2025cites this paper
• Adaptation to acidic conditions that mimic the tumor microenvironment, downregulates miR-193b-3p, and induces EMT via TGFβ2 in A549 cells

  2025cites this paper
• Discovery of a Selective, Novel TGF-βR1 Inhibitor GFH018 for the Treatment of Solid Tumors.

  2025cites this paper
• The role of transforming growth factor β in cervical carcinogenesis.

  2024cites this paper
• ATP6V0A1-dependent cholesterol absorption in colorectal cancer cells triggers immunosuppressive signaling to inactivate memory CD8+ T cells

  2024cites this paper
• Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles

  2024cites this paper
• Classification of the Tumor Immune Microenvironment Using Machine-Learning-Based CD8 Immunophenotyping As a Potential Biomarker for Immunotherapy and TGF-β Blockade in Nonsmall Cell Lung Cancer

  2024cites this paper
• A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update

  2024cites this paper
• Using Pharmacokinetic–Pharmacodynamic Modeling to Study the Main Active Substances of the Anticancer Effect in Mice from Panax ginseng–Ophiopogon japonicus

  2024cites this paper
• Polyploid giant cancer cells, cytokines and cytomegalovirus in breast cancer progression

  2023cites this paper
• Therapeutic Potential of Targeting Transforming Growth Factor-beta (TGF-β) and Programmed Death-ligand 1 (PD-L1) in Pancreatic Cancer.

  2023cites this paper
• Keloid Core Factor CTRP3 Overexpression Significantly Controlled TGF-β1-Induced Propagation and Migration in Keloid Fibroblasts

  2023cites this paper
• Effect of Poly(methacrylic acid) on the Cytokine Level in an In Vivo Tumor Model

  2022cites this paper
• Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma via Regulating the Hippo Signaling Pathway by Targeting STK25

  2022cites this paper
• A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages.

  2022cites this paper
• TGF-β at the crossroads of multiple prognosis in breast cancer, and beyond.

  2022cites this paper
• Recent advances in overcoming barriers to cell‐based delivery systems for cancer immunotherapy

  2022cites this paper
• Identification of Novel Endogenous Controls for qPCR Normalization in SK-BR-3 Breast Cancer Cell Line

  2021cites this paper
• Therapeutic Potential of Thymoquinone in Triple-Negative Breast Cancer Prevention and Progression through the Modulation of the Tumor Microenvironment

  2021cites this paper
• Transforming Growth Factor β1 (TGF β1) mRNA Expression and Tumor Necrosis Factor mRNA Expression (TNF) in Endometrial Cancer Versus Normal Endometrial Tissue: Macrophages Polarization Markers?

  2021cites this paper
• TGFβ Signaling in the Tumor Microenvironment.

  2021cites this paper
• Identi cation and Validation of Novel Endogenous Controls for qPCR Normalization in SK-BR-3 Breast Cancer Cell Line

  2021cites this paper
• Prognostic impact of lncRNA-ATB expression in malignant solid tumors: A meta-analysis.

  2020cites this paper
• Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer Model

  2020cites this paper
• The interplay of Klotho with signaling pathway and microRNAs in cancers

  2019cites this paper
• Nodal induces apoptosis and inhibits proliferation in ovarian endometriosis-clear cell carcinoma lesions

  2019cites this paper
• Aspirin and metformin exhibit antitumor activity in murine breast cancer.

  2018cites this paper
• Differential role of PTEN in transforming growth factor β (TGF‐β) effects on proliferation and migration in prostate cancer cells

  2018cites this paper
• Klotho negatively regulated aerobic glycolysis in colorectal cancer via ERK/HIF1α axis

  2018cites this paper
• Alcoholic extract of Tarantula cubensis induces apoptosis in MCF-7 cell line

  2017cites this paper
• Neutrophil programming dynamics and its disease relevance

  2017cites this paper
• TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion

  2017cites this paper
• MiR‐9 is involved in TGF‐β1‐induced lung cancer cell invasion and adhesion by targeting SOX7

  2017cites this paper
• Cancer Stem Cells and Metastasis.

  2017cites this paper
• UPDATES AND ADDITIONS for Herbal Contraindications &Drug Interactions plus Herbal Adjuncts with Medicines

  2016cites this paper
• SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis

  2016cites this paper
• Effects of RECQ1 helicase silencing on non-small cell lung cancer cells.

  2016cites this paper
• Role of chitinase-like proteins in cancer

  2016cites this paper
• TLR2/1 Orchestrate Human Plasmacytoid Dendritic Cells Response to Gram+ Bacteria

  2016cites this paper
• The Role of Alpha-Klotho as a Universal Tumor Suppressor.

  2016cites this paper
• Expression of CDKN 1 A / p 21 and TGFBR 2 in breast cancer and their prognostic significance

  2015cites this paper
• In situ hybridization analysis of the expression of miR-106b in colonic cancer.

  2015cites this paper
• Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance.

  2015cites this paper
• Prognostic value of miR-106b expression in breast cancer patients.

  2015cites this paper
• Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

  2015cites this paper
• The Disintegrin and Metalloprotease ADAM12 Is Associated with TGF-β-Induced Epithelial to Mesenchymal Transition

  2015cites this paper
• Cerebrospinal fluid protein dynamic driver network: At the crossroads of brain tumorigenesis.

  2015cites this paper
• Relationships Between SMAD3 Expression and Preoperative Fluoropyrimidine-Based Chemoradiotherapy Response in Locally Advanced Rectal Cancer Patients

  2015cites this paper
• Prognostic significance of the tumour-adjacent tissue in head and neck cancers

  2015cites this paper
• The Role of Cytokines in Breast Cancer Development and Progression

  2015cites this paper
• Original Article Expression of CDKN1A/p21 and TGFBR2 in breast cancer and their prognostic significance

  2015cites this paper
• Construction of eukaryotic expression vector pTAR-GET- DNTβRII and its expression in breast cancer COS-7 cells

  2015cites this paper
• MicroRNA‐125b attenuates epithelial‐mesenchymal transitions and targets stem‐like liver cancer cells through small mothers against decapentaplegic 2 and 4

  2015cites this paper
• Biomarkers of TGF-β Signaling Pathway and Prognosis of Pancreatic Cancer

  2014cites this paper
• PKM2 and ACVR 1C are prognostic markers for poor prognosis of gallbladder cancer

  2014cites this paper
• P130cas is required for TGF-β1-mediated epithelial-mesenchymal transition in lung cancer

  2014cites this paper
• Guiding the Lasso: Regression in High Dimensions

  2013cites this paper
• Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

  2013cites this paper
• Knockdown of prolyl‐4‐hydroxylase domain 2 inhibits tumor growth of human breast cancer MDA‐MB‐231 cells by affecting TGF‐β1 processing

  2013cites this paper
• Erratum to: Suppression of malignancy by Smad3 in mouse embryonic stem cell formed teratoma

  2013cites this paper
• The complex roles of microRNAs in the metastasis of renal cell carcinoma.

  2013cites this paper
• Loss of TAK1 increases cell traction force in a ROS-dependent manner to drive epithelial–mesenchymal transition of cancer cells

  2013cites this paper
• Radiotherapy of Human Sarcoma Promotes an Intratumoral Immune Effector Signature

  2013cites this paper
• Secretome and degradome profiling shows that Kallikrein‐related peptidases 4, 5, 6, and 7 induce TGFβ‐1 signaling in ovarian cancer cells

  2013cites this paper
• 2012 Landes Bioscience. Do not distribute. The role of the myofibroblast in tumor stroma remodeling

  2012cites this paper
• uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway

  2012cites this paper
• Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity

  2012cites this paper
• Dysregulation of Cell Polarity Proteins Synergize with Oncogenes or the Microenvironment to Induce Invasive Behavior in Epithelial Cells

  2012cites this paper
• Using mice to unveil the genetics of cancer resistance.

  2012cites this paper
• Expression of TGFβ3 and its effects on migratory and invasive behavior of prostate cancer cells: involvement of PI3-kinase/AKT signaling pathway

  2012cites this paper
• Characterization of breast cancer interstitial fluids by TmT labeling, LTQ-Orbitrap Velos mass spectrometry, and pathway analysis.

  2012cites this paper
• Alterations in Cerebrospinal Fluid Proteins in a Presymptomatic Primary Glioma Model

  2012cites this paper
• The impact of TGF-β1 on the mRNA expression of TβR I, TβR II, Smad4 and the invasiveness of the JEG-3 placental choriocarcinoma cell line.

  2012cites this paper
• Overexpression of histone deacetylase 6 contributes to accelerated migration and invasion activity of hepatocellular carcinoma cells.

  2012cites this paper
• regulation of the invasion and metastasis of human glioma cells by polypeptide N-acetylgalactosaminyltransferase 2.

  2011cites this paper
• Mise en évidence de variants de la protéine de capside du virus de l’Hépatite C et de leurs effets sur la signalisation du TGF-_

  2011cites this paper
• TGF-β1 increases invasiveness of SW1990 cells through Rac1/ROS/NF-κB/IL-6/MMP-2.

  2011cites this paper
• Butterfly effect and cancer.

  2011cites this paper
• Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update

  2011cites this paper
• Analysis of Normal-Tumour Tissue Interaction in Tumours: Prediction of Prostate Cancer Features from the Molecular Profile of Adjacent Normal Cells

  2011cites this paper
• TGF-β and its coreceptors in cancerogenesis: an overview.

  2011cites this paper
• Expression and clinical significance of the transforming growth factor‐β signalling pathway in endometrial cancer

  2011cites this paper
• Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2

  2011cites this paper
• In silico Analysis of Combinatorial microRNA Activity Reveals Target Genes and Pathways Associated with Breast Cancer Metastasis

  2011cites this paper
• Weighted Lasso with Data Integration

  2011cites this paper
• Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy

  2010cites this paper
• Genetic Variation in the TGF-β Signaling Pathway and Colon and Rectal Cancer Risk

  2010cites this paper
• The role of transforming growth factor-b in suppression of hepatic metastasis from colon cancer

  2010cites this paper
• The role of transforming growth factor-β in suppression of hepatic metastasis from colon cancer

  2010cites this paper